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Diabetes mellitus (DM) is the most widespread metabolic disorder affecting 
millions worldwide. Molecular docking studies are useful in identifying some 
useful ligands which could be used to target proteins related to β-cell 
protection.  Flindersine isolated from the plant Toddalia asiatica (L.) Lam. 
(Rutaceae) has been shown by us to possess antidiabetic property. With a view 
to identify in silico the possible mode of docking with different target proteins 
like PPARγ and GLUT4 which play important roles in protecting β-cells from 
damage. Chemical characteristics of Flindersine were retrieved from pubchem 
database http://pubchem.ncbi.nlm.nih.gov. The docking analysis in the active 
sites of 2PRG and Homology modeled protein structure of GLUT4 were 
performed by the Auto dock program. The docking results showed good 
binding interactions of the ligand with both the targets at very low energy level. 
In our in silico analysis, flindersine isolated from Toddalia asiatica clearly 
demonstrated that it could improve  diabetic condition by increasing insulin 
secretion from remnant or regenerated pancreatic beta cells and could promote 
insulin sensitization and glucose uptake activities. When compared with 
standard drug Rosiglitazone that is commercially available flindersine can 
further diminish the degree of shrinkage and necrosis of beta cells of pancreas. 
Thus flindersine can be considered for developing into a potent antidiabetic 
drug.   
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1. INTRODUCTION 
 Diabetes mellitus (DM) is a chronic metabolic disorder characterized by hyperglycemia that afflicts 
severely the world population. DM is classified into two types (type 1 and type 2). Type 2diabetes is sharply 
increasing globally, including in many parts of the developing world. It is expected that about 366 million 
people are likely to be diabetic by the year 2030 (Wild et al., 2004). Plants are acknowledged as a good source 
for medicines. In India, lots of plants are used traditionally for the management and control of diabetes mellitus 
as alternatives to synthetic antidiabetic drugs. (Singh et al., 2007).One such plant is Toddalia asiatica (L.) Lam. 
belonging to the family Rutaceae. The fruit is traditionally used to treat malaria and coughs; roots are used to 
treat indigestion and influenza and the leaves are used to treat diabetes, lung diseases and rheumatism 
(Muthumani et al., 2010; Rajkumar et al., 2010; Duraipandiyan et al., 2006; Karunai Raj et al., 2012). 
Compound flindersine was isolated from T. asiatica previously at our institute. (Duraipandiyan et al., 2009). 
Bioinformatics tools have become very significant to pinpoint the targets for different ligands. We made an 
attempt in using bioinformatics tools to evaluate whether flindersine is a good ligand to some of the target 
proteins related to diabetes such as PPARγ and GLUT4. The above mentioned targets were subjected to in 
Silico docking with a view to identify whether flindersine could be a good molecule to treat diabetes. 
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2. RESEARCH METHOD 
 Plant material, method of extraction, isolation and identification of the active compound (flindersine) 
procedures were published in our previous manuscript (Duraipandiyan et al., 2009). 
 
2.1 Ligand preparation 
 Chemical structure of ligand (flindersine) was taken from Pubchem compound database, 
(http://www.ncbi.nlm.nih.gov/search). Three dimensional structures for flindersine were generated using 
ChemDraw Ultra 11. 
 
2.2 Protein selection 
 Three dimensional structures of PPARγ (PDB ID: 2PRG), were retrieved from the Protein Data Bank 
(PDB), (http://www.pdb.org). GLUT4 protein structure was taken from our previous published manuscript 
(G.R. Gandhi et al., 2013). 
 
2.3 Docking analysis  
 The docking analyses of flindersine were carried out by means of the Autodock tools (Sanner, 1999) 
(ADT) v1.5.4 and Autodock v4.2 program; (Autodock, Autogrid, Autotors, Copyright-1991e2000) from the 
Scripps Research Institute, http://www.scripps.edu/mb/olson/doc/ Autodock. To run autodock, we used a 
searching grid extended over the selected target proteins; polar hydrogens were added to the ligand moieties. 
Kollman charges were assigned and atomic solvation parameters were added. Polar hydrogen charges of the 
Gasteiger-type were assigned and the non polar hydrogens were merged with the carbons and the internal 
degrees of freedom and torsions were set. Flindersine was docked to all the target protein complexes with the 
molecule considered as a rigid body and the ligand being flexible. The search was extended over the whole 
receptor protein used as blind docking. Affinity maps for the entire atom types were present, as well as an 
electrostatic map was computed with a grid spacing of 0.375 E. The search was carried out with the Lamarckian 
Genetic Algorithm (Morris et al., 1998). Populations of 150 individuals with a mutation rate of 0.02 have been 
evolved for 10 generations. Evaluation of the results was done by sorting the different complexes with respect to 
the predicted binding energy. A cluster analysis based on root mean square deviation values, with reference to 
the starting geometry, was subsequently performed and the lowest energy conformation of the more populated 
cluster was considered as the most trustable solution. The hydrophobic effect of ligand was retrieved by 
ALOGPS 2.1. This Applet provides interactive online prediction of logP, water solubility and pKa(s) of 
compounds for drug design (ADME/T and HTS) and environmental chemistry studies (Stierand, 2010). 
 
3. RESULTS AND ANALYSIS 
3.1. Flindersine and its antidiabetic activity 
 Flindersine is one of the compounds isolated from the plant Toddalia asiatica. It has been traditionally 
used for the treatment of diabetes mellitus. We had previously carried out to determine the antidiabetic and 
antioxidant activities of T. asiatica leaves in STZ-induced diabetic rats. (S. Stephen Irudayaraj et al., 2012). The 
antidiabetic effect of flindersine was evaluated using the Streptozotocin (STZ) induced diabetic rat model in vet 
lab. Diabetic rats treated with 20 mg/kg flindersine significantly reduced fasting blood glucose level and 
decreased glycosylated haemoglobin (66.96%), glucose-6-phosphatase (40.07%), decreased liver marker 
enzymes such as AST, ALT, ALP and ACP along with lipid profile and significantly increased plasma insulin 
(69.05%), liver glycogen (77.15%) and muscle glycogen content (76.86%) and glucose 6 phosphate 
dehydrogenase (38.52%). Flindersine is a quinolone alkaloid. Reports are available for the antidiabetic activity 
of quinolones (Marles and Farnsworth, 1995). Hence the activity of T. asiatica leaves may be due to the 
presence of flindersine.  
 
3.2. Chemical characteristic of Flindersine 
 Chemical characteristics of Flindersine were retrieved from pubchem database 
http://pubchem.ncbi.nlm.nih.gov/, Molecular Weight 227.25852 [g/mol], Molecular Formula C14H13NO2, 
XLogP3-AA: 2, HBond Donor: 1, H-Bond Acceptor: 2, Rotatable Bond Count: 0, Exact Mass: 227.094629, 
IUPAC Name: 2,2-dimethyl-6H-pyrano[3,2-c]quinolin-5-one.SMILES: CC1(C=CC2=C(O1)C3=CC=CC= 
C3NC2=O)C. The Chemical properties were also checked in the ALOGPS 2.1. Chemical Formula: 
C14H13NO2, MW: 227.28, SMILES: CC1(C=CC2=C(O1)C3=CC=CC=C3NC2=O)C, ALOGPs: 2.58, 
ALOGpS: -3.12, AC_logP: 2.18, AC_logS: -2.84, Average logs: -2.98, ALOGP: 1.52, MLOGP: 2.23, 
KOWWIN: 2.19, XLOGP2: 2.33, XLOGP3: 1.99, Average logP: 2.14  (Tetko et al., 2005).  
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3.3. Docking analysis 
 The docking analysis in the active sites of 2PRG and Homology modeled protein structure of GLUT4 
were performed by the Auto dock program. It has been shown effectively and observed experimentally the 
binding affinities in terms of lowest docking energy. The target protein structure of 2PRG and GLUT4 were 
docked with flindersine which provided significant results by the least values of the binding energy. The best 
possible binding affinities of the flindersine at two targeted protein’s active sites are displayed and their 
corresponding energy values are listed in Table 1 by using PYMOL tool v 1.1 
 
 
Table 1: Docked amino acid residues of target proteins and their interactions with Flindersine and Rosiglitazone. 
Ligand Protein Amino acid Interaction 
Energy Value 
(kcal/mol) 
Inhibition Constant 
(nM) 
RMSD 
Flindersine 
2PRG (PPAR-
Gamma) 
ARG`288/HE with 43 atoms, LEU`340/O 
with 19 atoms 
-7.2 5.24 83.35 
 GLUT4 GLY`302/O with 7 atoms -8.27 863.44 63.55 
Rosiglitazone 2PRG 
ARG`288/HE with 42 atoms, HIS`449/HE2 
with 18 atoms 
-8.18 1.01 58.31 
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Fig. 2 (a)  shows the result of docking analysis of PPAR Gamma (2PRG) with flindersine; it showed the binding 
site of the protein and ligand ARG’288/HE with 43 atoms and LEU’340/O with 19 atoms. Fig. 3 (a) Glucose 
Transporter 4 (GLUT4) showed binding interaction of protein with ligand GLY-302/O with 7 atoms when 
docked with lead molecule flindersine.  Fig. 4 (a). Our reference drug Rosiglitazone docked with PPAR Gamma 
(2PRG) showed the binding site of ARG`288/HE with 42 atoms and HIS`449/HE2 with 18 atoms.  Hydrophobic 
interaction of the ligand-protein images are showed in figures 2(b), 3(b), 4(c). 
 
4. CONCLUSION 
 Docking studies of the ligand flindersine confirmed that this is a good molecule which docks well with 
target proteins like PPARγ and GLUT4 with least energy values and it can improve glycaemic control 
mechanism in diabetic condition by increasing insulin secretion from remnant or regenerated pancreatic beta 
cells. When compared with standard drug Rosiglitazone that is commercially available flindersine can further 
diminish the degree of shrinkage and necrosis of beta cells of pancreas. In our in silico studies, flindersine 
isolated from Toddalia asiatica clearly demonstrated that it could be promoted insulin sensitization and glucose 
uptake activities by beta cells protective effects. Thus flindersine can be considered for developing into a potent 
antidiabetic drug.  
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